Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

Journal of Clinical Oncology

Volumn 22, Issue 1, 2004, Pages 69-76

  Denis, Fabrice ^a   Garaud, Pascal ^a   Bardet, Etienne ^a   Alfonsi, Marc ^a   Sire, Christian ^a   Germain, Thierry ^a   Bergerot, Philippe ^a   Rhein, Beatrix ^a   Tortochaux, Jacques ^a   Calais, Gilles ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

ARTICLE; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FRANCE; HEMOGLOBIN DETERMINATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; OROPHARYNX CARCINOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TOXICITY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS;

EID: 3042701812     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.08.021     Document Type: Article

References (28)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1996. Cancer J Clin 65:5-27, 1996
2. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1998
3. Dose specification for reporting external beam therapy with photons and electrons: ICRU report 29. International Commission on Radiation Units and Measurements, Washington, DC, 1978
4. Denis F, Garaud P, Bardet E, et al: Late toxicity results of the GORTEC 94-01 randomized trial comparing radiation therapy with concomitant radio-chemotherapy for advanced-stage oropharynx carcinoma: Comparison of LENT/SOMA, RTOG/EORTC and NCI/CTC scoring systems. Int J Radiat Oncol Biol Phys 55:93-98, 2003
5. Rubin P, Constine S, Fajardo LF, et al: Late effect consensus conference: RTOG/EORTC. Radiother Oncol 35:5-7, 1995
6. Mornex F, Pavy JJ, Denekamp J, et al: Late effect of normal tissue (LENT) scoring system: The SOMA scale. Cancer Radiother 1:622-627, 1997
7. Galen RS: Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med 2:685-699, 1982
8. Tosteson AN, Weinstein MC, Wittenberg J. et al. ROC curve regression analysis: The use of ordinal regression models for diagnostic test assessment. Environ Health Perspect 102:73-81, 1994 (suppl 8)
9. Guttman LA: Some necessary conditions for factor analysis. Psychometrika 19:149-154, 1954
10. Tenenhaus M, Young FW: An analysis and synthesis of multiple correspondence analysis, optimal scaling, dual scaling, homogeneity analysis, and other methods for quantifying categorial multivariate data. Psychometrika 50:91-119, 1985
11. Burt C: Test of significance in factor analysis. Br J Psychol 5:109-133, 1952
12. Thioulouse J: Statistical analysis and graphic display of multivariate data on the Macintosh. Comput Appl Biosci 5:287-292, 1989
13. Fein DA, Lee WR, Amos WR, et al: Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience. Int J Radiat Oncol Biol Phys 34:289-296, 1996
14. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group-Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949-955, 2000
15. Haselow RE, Warshaw MG, Okin MM, et al: Radiation alone versus radiation plus weekly low-dose cis-platinum in unresectable cancer of the head and neck. In: Fee WE, Goepfert H, Johns ME, Strong EW, Ward PH (eds), Head and Neck Cancer (ed 1). Toronto, Canada, Marcel Dekker, 1990, pp 279-281
16. Jeremic B, Shibamoto Y, Stanisavljevic B, et al: Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial. Radiother Oncol 43:29-37, 1997
17. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575, 1997
18. Horiot JC, Bontemps P, Begg AC, et al: Hyperfractionated and accelerated radiotherapy in head and neck cancers: Results of the EORTC trials and impact on clinical practice. Bull Cancer Radiother 83:314-320, 1996
19. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
20. Wendt TG, Grabenbauer GG, Rodel CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998
21. Staar S, Rudat V, Stuetzer H, et al: Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:1161-1171, 2001
22. Laszlo A, Rosset A, Hermann F, et al: T.i.d. radiotherapy with or without alternating chemotherapy in patients with a locally advanced squamous cell carcinoma of the head and neck: An analysis of late toxicity. Cancer Radiother 5:130-137, 2001
23. Hoeller U, Tribius S, Kuhlmey A, et al: Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 55:1013-1018, 2003
24. Kumar P: Impact of anemia in patients with head and neck cancer. Oncologist 5:13-18, 2000
25. Dubray B, Mosseri V, Brunin F, et al: Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study. Radiology 201:553-558, 1996
26. Vaupel P, Schlenger K, Knoop C, et al: Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51:3316-3322, 1991
27. Rudat V, Stadler P, Becker A, et al: Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 177:462-468, 2001
28. Dunst J. Hemoglobin level and anemia in radiation oncology: Prognostic impact and therapeutic implications. Semin Oncol 27:4-8, 2000 (suppl 4)